Original Article from The New England Journal of Medicine — Lipoprotein Lipase Inhibition in the Hyperlipemia of Acute Alcoholic Pancreatitis ...

Recently, the enzyme lipoprotein lipase (LPL) has been implicated in the normal physiology of lipemia clearing. 8,9 This enzyme, which appears to be identical with the postheparin-clearing factor ...

Lipoprotein lipase releases the fatty acids from triglycerides. Once most of the triglycerides are removed from the chylomicron, the remnant is cleared by the liver B/E receptor.

These medications rely on your body having a functioning lipoprotein lipase enzyme in order to work. Familial hyperchylomicronemia syndrome diet. To help manage your FCS, ...

Lipoprotein lipase (LPL) hydrolyzes circulating triglycerides (TGs). We previously showed that 3′-end haplotypes in the LPL gene influence atherosclerosis and insulin resistance. This study ...

Lipoprotein lipase is responsible for triglyceride metabolism primarily. And we want to have more lipoprotein lipase activity to reduce severe hypertriglyceridemia.

Purpose: Our aim was to test whether polymorphisms in the lipoprotein lipase (LPL) gene were associated with the progression of atherosclerosis in grafts examined in the Post-Coronary Artery ...

Pancreatitis reduced by nearly 50% after gene therapy to treat lipoprotein lipase deficiency Date: November 8, 2016 Source: Mary Ann Liebert, Inc., Publishers ...

During the first 18 months after treatment with ali-pogene tiparvovec, a gene therapy recently approved in Europe to treat lipoprotein lipase deficiency (LPLD), the first patient to receive the ...

Last September, she gave 40 injections to the muscles of a 43-year-old woman with an ultra-rare disease called lipoprotein lipase deficiency. Such patients don’t process fat correctly.

Glybera was developed by Canadian scientists to treat a rare but devastating disease called lipoprotein lipase deficiency (LPLD). The disease affects about one or two out of every million ...